Timing of consolidation durvalumab significantly impacts survival for patients with locally advanced non-small cell lung ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.

Huntington's disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a ...

Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...

Energy Fuels Inc. (NYSE: UUUU) (TSX: EFR) (Energy Fuels or the Company), a leading U.S. producer of uranium, rare earth elements (REEs), and other critical materials, today released the results of a ...

The global Central Nervous System (CNS) therapeutic market is projected to reach US$ 235.87 billion by 2033. This growth is ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

A new study published in the Chest Journal showed that Full MIST2 dosing of intrapleural enzyme therapy (IET) was Linked to ...

French Member of the European Parliament Virginie Joron speaks during a Stop Violence Against Women conference at the ...

As drug pricing pressure intensifies and benefit structures shift, some health systems are still treating biosimilars as a selective cost lever — deploying them in certain payer segments while ...

Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.

Objective: To investigate the effects of rehabilitation-initiation timing (RIT) and rehabilitation-hospitalization frequency (RHF) on activities of daily living (ADL) evaluated at 6 months post-stroke ...